date,title,source
Oct-18-18,"Cytokinetics to Announce Third Quarter Results on November 1, 2018",GlobeNewswire
Nov-01-18,"Cytokinetics (CYTK) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-01-18,Cytokinetics: 3Q Earnings Snapshot,Associated Press
Nov-01-18,"Cytokinetics, Inc. Reports Third Quarter 2018 Financial Results",GlobeNewswire
Nov-05-18,Edited Transcript of CYTK earnings conference call or presentation 1-Nov-18 8:30pm GMT,Thomson Reuters StreetEvents
Nov-07-18,Cytokinetics to Participate in Upcoming Investor Conferences,GlobeNewswire
Nov-20-18,Cytokinetics Sees Hammer Chart Pattern: Time to Buy?,Zacks
Nov-26-18,Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND,GlobeNewswire
Nov-27-18,"Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Nov-27-18,"Cytokinetics Completes Enrollment in FORTITUDE-ALS, Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS",GlobeNewswire
Dec-03-18,"Jim Cramer Gives His Opinion On Netflix, Kraft Heinz And More",Benzinga
Dec-10-18,Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND,GlobeNewswire
Jan-04-19,"Could Cytokinetics, Incorporateds (NASDAQ:CYTK) Investor Composition Influence The Stock Price?",Simply Wall St.
Jan-22-19,Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA,GlobeNewswire
Feb-07-19,"Cytokinetics to Announce Fourth Quarter Results on February 21, 2019",GlobeNewswire
Feb-13-19,5 Tiny Biotech Stocks With Superb Growth Potential,Zacks
Feb-14-19,"The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna",Zacks
Feb-14-19,Will Cytokinetics (CYTK) Report Negative Earnings Next Week? What You Should Know,Zacks
Feb-20-19,"Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator",GlobeNewswire
Feb-21-19,"Cytokinetics (CYTK) Reports Q4 Loss, Tops Revenue Estimates",Zacks
Feb-21-19,Cytokinetics: 4Q Earnings Snapshot,Associated Press
Feb-21-19,Cytokinetics Reports Fourth Quarter 2018 Financial Results,GlobeNewswire
Feb-21-19,"Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure",PR Newswire
Feb-21-19,"Amgen, Cytokinetics and Servier Announce Start of METEORIC-HF, the Second Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure",GlobeNewswire
Feb-22-19,Amgen Starts Phase III Enrollment for Heart Failure Drug,Zacks
Feb-22-19,Edited Transcript of CYTK earnings conference call or presentation 21-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Feb-27-19,Edited Transcript of CYTK earnings conference call or presentation 21-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Feb-28-19,Cytokinetics Joins Global Initiative To Recognize International Rare Disease Day,GlobeNewswire
Feb-28-19,Edited Transcript of CYTK earnings conference call or presentation 21-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-01-19,Edited Transcript of CYTK earnings conference call or presentation 21-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-07-19,Cytokinetics Announces Presentation of Results From FORTITUDE-ALS at the American Academy of Neurology 71st Annual Meeting,GlobeNewswire
Mar-07-19,Some Cytokinetics Shareholders Are Down 43%,Simply Wall St.
Mar-07-19,"Cytokinetics Inc (CYTK) Files 10-K for the Fiscal Year Ended on December 31, 2018",GuruFocus.com
Mar-11-19,Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at ACC.19,GlobeNewswire
Mar-11-19,Edited Transcript of CYTK earnings conference call or presentation 21-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
